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INVITED REVIEW
INFECTIOUS AGENTS IN CORONARY ATHEROMAS: A POSSIBLE ROLE IN THE PATHOGENESIS OF
PLAQUE RUPTURE AND ACUTE MYOCARDIAL INFARCTION
Maria de Lourdes HIGUCHI & Jose A. F. RAMIRES
SUMMARY
In this review we report our recent findings of histopathological features of plaque instability and the association with Mycoplasma
pneumoniae (MP) and Chlamydia pneumoniae (CP) infection, studying thrombosed coronary artery segments (CAS) of patients who
died due to acute myocardial infarction. Vulnerable plaques are known to be associated with fat atheromas and inflammation of the
plaque. Here we demonstrated that vulnerability is also related with focal positive vessel remodeling that maintains relatively well
preserved lumen even in the presence of large atheromatous plaques. This phenomena may explain why the cinecoronariography may
not detect large and dangerous vulnerable plaques. Greater amount of these bacteria in vulnerable plaques is associated with adventitial
inflammation and positive vessel remodeling: the mean numbers of lymphocytes were significantly higher in adventitia than in the
plaque, good direct correlation was obtained between numbers of CD20 B cells and numbers of CP infected cells in adventitia, and
between % area of MP-DNA in the plaque and cross sectional area of the vessel, suggesting a cause-effect relationship. Mycoplasma
is a bacterium that needs cholesterol for proliferation and may increase virulence of other infectious agents. In conclusion, co-
infection by Mycoplasma pneumoniae and Chlamydia pneumoniae may represent an important co-factor for plaque instability, leading
to coronary plaque thrombosis and acute myocardial infarction, since larger amount of these bacteria strongly correlated with histological
signs of more vulnerability of the plaque. The search of CMV and Helicobacter pilori in these tissues resulted negative.
KEYWORDS: Chlamydia pneumoniae; Mycoplasma pneumoniae; Infection; Atherosclerosis; Vulnerable plaque, Myocardial
infarction.
INTRODUCTION
Many works have tried to associate infectious agents in the
development of atherosclerosis and acute myocardial infarction30,31
mainly the Chlamydia pneumoniae (CP)8,12,23,25. Nevertheless, the results
are controversial5,29 and the serological data can not discriminate patients
who will develop acute myocardial infarction (AMI)7. Inflammation in
the atherosclerotic plaque is accepted to be linked to plaque
instability3,10,17. High level of cholesterol in the blood seems to be the
most frequent associated risk factor, but it is difficult to explain why
cholesterol causes inflammation. On the other hand, the accelerated
progression of systemic atherosclerosis in some autoimmune rheumatic
diseases, such as systemic lupus erythematosus, antiphospholipid
syndrome, rheumatoid arthritis and vasculitis, have led the authors to
implicate autoimmune mechanisms in development of atherosclerosis24.
We performed a series of works analyzing deeply the
histopathological characteristics of ruptured plaque and compared with
stable plaques of the same and different patients, regarding the
constituents and size of the plaque, remodeling of the wall and plaque
and adventitial inflammation. We also search for some infectious agents,
using different techniques (immunohistochemistry, in situ hibridization
and electron microscopy) in the same material in order to diminish the
false positive or negative results. The results of these works are divided
in 4 sections.
1- Fatal thrombosed atheromas are associated with larger plaques
and positive remodeling2: Several lines of clinical and angiographic
evidences have shown that acute myocardial infarction (AMI) frequently
occurs at sites with mild to moderate degree of coronary stenosis. The
degree of luminal stenosis depend not only on plaque deposition but
also on the type and degree of vessel remodeling4,8. Coronary angiography
cannot assess the amount of plaque and vessel remodeling. Recent
intravascular ultrasound studies have shown different types of vascular
remodeling in plaques with diverse composition and clinical
presentations19,26,27. Positive remodeling was associated with vulnerable
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Fig. 1 - Histological views of unstable and stable coronary atheromas. Fig.1A - Ruptured thrombosed segment showing expanded vessel containing a large fat plaque and a thinned medial layer
(RC - right coronary - Movat stain). On the right top, a detailed view of the adventitial inflammatory infiltrate at the confocal laser microscopy, the external elastic membrane (EEM) in green
fluorescence exhibiting holes (arrow) and the lymphocytes stained in yellow. On the right bottom, histological detail of the adventitial and medial inflammatory infiltrate associated with EEM
fragmentation and medial layer attenuation. Fig. 1B is a schematic representation of a thrombosed coronary artery segment presenting inflammation in all layers of the vessel, positive
remodeling, large fat plaque, and a wide lumen occluded by a thrombus. Fig. 1C is an equi-stenotic stable segment from the same patient of Fig. 1A, exhibiting a smaller fibrotic plaque that
causes more obstructive injury due to the vessel negative remodeling (DA - descending anterior artery - Movat stain). Fig. 1D - Schematic representation of a stable coronary artery segment
presenting a small fibrotic plaque causing severe obstruction of the lumen due to the negative remodeling of the vessel; there was no inflammation on the wall.
Table 1
Mean cross-sectional areas (mm2) of the coronary artery segments with stable and unstable (culprit) atherosclerotic lesions from the same individuals
Layer Adventitia Intimal plaque
Lymphocytes/ mm2 Culprit lesion (n = 34) Stable lesion (n = 34) Culprit lesion (n = 34) Stable lesion (n = 34)
CD20-B * 34.0 ± 58.1 5.9 ± 13.2 5.4 ± 16.7 1.9 ± 4.4
CD8-T * 20.5 ± 30.3 5.0 ± 5.7 13.6 ± 23.4 5.6± 7.5
CD4-T *§ 16.2 ± 19.4 5.8 ± 7.8 6.2 ± 7.0 3.4 ± 4.1
Total *§ 69.5 ± 88.3 16.4 ± 21.2 24.0 ± 40.8 10.9 ± 13.2
*- Differences between culprit and stable lesions in the adventitia are significant; §- Differences between culprit and stable lesions in the intimal plaque are
significant; - Differences between adventitia and intimal plaques in culprit lesions are significant. No other difference was significant.
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plaques and negative remodeling with stable ones. In the present post-
mortem study we tested the hypothesis that the size of coronary atheroma
and the type of remodeling distinguish culprit lesion responsible for
fatal AMI from equi-stenotic lesion in the same coronary tree.
The main coronary branches from 36 consecutive patients with fatal
AMI were histologically studied. The culprit lesion (Group A),
responsible for vascular occlusion and fatal AMI was compared with
equi-stenotic (histologically determined) stable plaque (Group B),
obtained in another coronary branch from the same patient. Morphometric
measurements included areas of the lumen, plaque and vessel and vascular
remodeling determined by the relative cross-sectional vessel area (lesion
vessel area/reference vessel area) X 100%. Positive remodeling was
defined as relative vessel area > 105% and negative remodeling when
relative vessel area was < 95%. Plaque composition measurement
included the % areas occupied by fibrosis, lipid core, macrophages (CD
68) and smooth muscle cells (HHF 35). Compared to Group B, Group A
had larger mean (SD) areas of plaque 9.6 (1.5) vs 4.7 (2.3) mm2, vessel
12.7 (4.9) vs 7.4 (3) mm2 and lumen 1.7 (1.5) vs 1.2 (0.86) mm2; (p <
0.01). Positive remodeling was more frequent in Group A than Group
B: 21/30 (70%) vs 8/26 (31%). Plaque area correlated positively with %
area of lipid core, r = 0.68 (p < 0.01) and with % area of macrophages,
r = 0.41 (p < 0.01). Plaque area related negatively with % area fibrosis,
r = -0.64 (p < 0.01) and with % area of smooth muscle cells, r = -0.48 (p
< 0.01). Negative remodeling was present in 19% of group B and in
only 3% of group A. Fig. 1A exemplifies a thrombosed ruptured plaque
of a patient died due to acute myocardial infarction, presenting positive
remodeling associated with medial thinning and less adventitial fibrosis.
Fig. 1B is a schematic demonstration of the characteristics of a vulnerable
segment. Fig. 1C is the histological representation of the stable plaque
exhibiting preserved medial layer, less positive remodeling and similar
degree of obstruction.
In conclusion, atherosclerotic plaques that cause thrombosis and fatal
acute myocardial infarction usually present vessel positive remodeling
and tend to be larger than equi-stenotic stable plaques.
2- Adventitial inflammation and attenuation of medial and
adventitial layers are associated with positive remodeling of the vessel
and plaque rupture11: Analyzing 34 of the CAS studied in above
described work, we searched if adventitial inflammation is associated
with positive remodeling and plaque vulnerability. The culprit lesion
segments (Group A) and non-culprit segments (Group B) were compared
regarding the mean numbers of lymphocytes in the adventitia and in the
plaque. Quantity of adventitial microvessels, adventitial fibrosis and,
using confocal laser microscopy, external elastic membrane were also
compared10,11. In the adventitia, the mean numbers of lymphocytes and
microvessels/mm2 were respectively 69.5 ± 88.3 and 60.9 ± 32.1 in the
culprit lesions; and 16.4 ± 21.1 and 44.3 ± 16.1 in stable lesions
(lymphocytes - p < 0.01; microvessels - p = 0.04). The most numerous
lymphocyte in adventitia was the CD20 B cell. Within the plaques, the
mean number of total lymphocytes was 24.0 ± 40.8 in culprit lesions
and 10.9 ± 13.2.06 in stable ones (p = 0.17), and a significant difference
was seen in CD4 T cells 6.2 ± 7.0 vs 3.4 ± 4.1 (p < 0.05); the most
numerous lymphocyte in the plaque was CD8 T cell. The mean percent
area of adventitial fibrosis/cross sectional area of the vessel was
significantly lower in unstable plaques (16.24 ± 5.07% vs 28.95 ± 9.76%
respectively; p < 0.001). Fig. 1A, closer views demonstrate inflammatory
infiltrate on the base of the plaque and in the medial and adventitial
layers, in a rupture plaque segment, that is not present in stable segments.
The inflammatory infiltrate releasing enzymes may have a role in the
pathogenesis of plaque rupture injuring the medial layer and adventitial
collagen. The confocal laser microscopy demonstrates in 3D view that
the external elastic membrane presents several holes associated with
lymphocytes (Fig. 1A, right top). Figures 1B and 1D show schematic
representation respectively of positive remodeling and inflammation
associated with vulnerable thrombosed plaque and negative remodeling
and absence of inflammation associated with stable occlusive plaques.
In conclusion, unstable plaques frequently exhibit chronic pan-arteritis,
accompanied by vessel dilatation, medial thinning, and diminished
adventitial collagen. Adventitial inflammation and not only the plaque
inflammation seems to be directly related with atheroma instability.
3 - Chlamydia pneumoniae in ruptured plaques: comparison with
stable atherosclerotic plaque and nonatherosclerotic coronary artery
segments12: In spite of a crescent number of papers trying to clarify if
CP is participating in the pathogenesis of plaque rupture in acute
myocardial infarction, this remains a non-clarified matter. Most of the
already published papers did not focus the ruptured thrombosed
plaques9,14,15,16,32. As above discussed, vulnerable plaques are associated
with adventitial inflammation and vessel positive remodeling. Here we
searched if CP was present in the adventitia of fatal ruptured thrombosed
segments.
Four groups of coronary artery segments from patients died at the
Instituto do Coração (InCor) do Hospital das Clínicas da Faculdade de
Medicina da Universidade de São Paulo were analyzed. Search of CP+
cells was performed using immunohistochemistry, in situ hybridization,
electron microscopy, and confocal laser microscopy.
Group A - fatal ruptured plaque from 23 AMI patients; Group B - 23
nonruptured equi-stenotic plaque from Group A patients; Group C -
stable atheromatous plaque from 11 non-AMI patients; Group D -
nonatherosclerotic coronary artery segments from 11 patients without
evidences of coronary artery disease.
The mean number of CP+ cells/ 400x field was obtained analyzing
immunostained slides. As positive controls were utilized a segment of
ruptured plaque presenting large number of CP+ cells at electron
microscopy and one paraffin block of rabbit lung severely infected with
C. pneumoniae.
We found that CP bodies were present in the adventitia and in the
intima of almost all cases of the four studied groups in the four techniques
used: immunohistochemistry, immunofluorescence (confocal laser
images) in situ hibridization and electron microscopy. The quantification
in immunohistochemistry (alkaline phosphatase) stained slides revealed
higher mean numbers of CP+ cells in group A than the other 3 groups.
Fig. 2A shows positive immunofluorescence against CP antigens in
adventitial fibroblasts of a ruptured plaque segment. Fig. 2B demonstrates
Chlamydia pneumoniae brown positive dots at in situ hybridization
technique (arrows) in the cytoplasm of fibroblast or at the extracellular
matrix. The electron microscopy confirmed a great amount of Chlamydia
pneumoniae elementary bodies in adventitia vasavasorum and
macrophages (Fig. 2C and Fig. 2D). They had a typical round central
eletron dense structure involved by two membranes, and presenting the
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Fig. 2 - Demonstration of Chlamydia pneumoniae (CP) in adventitia cells of vulnerable coronary atheroma segment through many different techniques. Fig. 2A - Two fibroblasts presenting
many CP bodies detected by immunofluorescence. Fig. 2B - In situ hybridization technique revealing CP-DNA in fibroblasts and inflammatory cells of adventitia and at the extracellular matrix.
Figs. 3C and 3D - electron micrographies respectively showing endothelial cell and macrophage with elementary bodies of CP in the cytoplasm characterized by electron dense core and “pear”
shape of the external membrane.
Table 2
Frequency and quantity of C. pneumoniae+ cells in unstable, stable and nonatherosclerotic groups of coronary artery segments
Group A unstable lesions Group B stable plaques Group C stable plaques Group D no atheroma
% C. pneumoniae + coronary artery segments
Adventitia 100% 91% 82% 82%
Plaque 96% 83% 82% 100%
C. pneumoniae + cells/mm2 (median number)
Adventitia 6.19 0.67 1.11 0.17
Plaque 2.33 0.27
A = ruptured plaque from patients who died of AMI; B = stable plaques from group A patients; C - stable plaques from patients who died without AMI; D -
coronary artery segments from patients without atherosclerosis; np - not performed
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expansion of external wall and the typical pear shape form. No difference
in the amount of CP+ cells was found among groups B, C, and D.
The mean numbers of CD+20B cells in adventitia correlated positively
with the mean numbers of CP+ cells positive by immunohistochemistry
(Fig. 4B ), suggesting a cause-effect relationship.
In this item we concluded that CP bacteria are frequently present in
cells of adventitia layer, in both atherosclerotic and nonatherosclerotic
coronary artery segments. However, significant higher numbers of them
are present in vulnerable plaque segments than the others. Increased
numbers of CD20 B cells correlated with increased numbers of CP in
adventitia, suggesting that CP contributes to the development of vessel
inflammation and plaque instability.
4 - Association between Mycoplasma pneumoniae and Chlamydia
pneumoniae in fatal thrombosed atherosclerotic coronary plaques13:
If CP is present in the adventitia of almost all coronary artery segments,
the next point is to clarify what is favoring CP proliferation and if it is
associated with severe inflammation and positive remodeling. Re-analysis
of electron microscopy specimens demonstrated another bacterium
adjacent to the CP bodies. This bacterium was recognized as mycoplasma
because it did not have the external wall and using the in situ hibridization
technique, as Mycoplasma pneumoniae (MP).
This finding was reported in a brief communication: the association
between MP and CP in thrombosed CAS13. It is known that mycoplasmas
are the only bacteria that require cholesterol in their membrane and for
proliferation21. Mycoplasmas have been considered as a typical parasite
of epithelium (respiratory and genitourinary tracts). It is believed that
mycoplasmas are not capable of invading the human body. However
here we demonstrated that intima of the arteries are usual habitat for
mycoplasmas. Here we tested the hypothesis that MP is in higher amounts
in vulnerable segments than in stable ones, associated with higher
amounts of fat, CP, inflammation and positive vessel remodeling.
Serial sections of the same 68 CAS described in the above CP study
were used.
 The electron microscopy specimens were revised.
A double staining for simultaneous detection of CP (by immuno-
histochemistry technique using the alkaline phosphatase as chromogen),
and of MP by ISH technique was performed in some cases.
The mean % areas of intima MP-DNA in the cases of both groups A
and B were compared with the mean numbers of CP + cells, of CD4+ T,
CD8+ T and CD20+ B cells, and % fat area in the plaques.
We found at the in situ hibridization slides MP bacteria as small
brownish granules in the lipidic areas of the plaques, both at the
extracellular matrix and in foam cells (Fig. 3A and 3B), mainly in the
unstable plaque group (groups A). The stable plaques that usually are
more fibrotic than lipidic showed much less MP into the plaque. MP
were also detected in the media and in the adventitia, usually in larger
forms.
In stable segments (groups B and C), a lower amount of MP was
detected in the plaque and almost absent in the media and absent or
scarce in the adventitia.
In group D (non-atherosclerotic group), MP were either absent or
present very scarcely in the subendothelial space.
The % area of MP and the mean number of CP+ cells, the % area of
fat and the mean number of lymphocytes/mm2 are shown in Table 3.
The mean % areas of MP-DNA were significantly higher in group A
(ruptured plaque) than in group B (stable plaques of the same patient) (p
< 0.01). There was no difference between groups B and C and they were
greater than group D.
Analyzing the stable and ruptured plaques from groups A and B
altogether, a significant correlation was obtained (Pearson test) between
the % area occupied by MP in the plaque and the % area of fat in the
plaque (r = 0.69) and with vessel cross-sectional area (r = 0.65). No
important correlation was seen with the mean number of lymphocytes
CD4+ T (r = 0.37), CD8+ T (r = 0.37), and CD20+ B (r = 0.018)
lymphocytes in the plaque.
At the electron microscopy, mycoplasmas could be identified by
their morphological unique characteristics: small irregular, tended to
round shape, measuring from 0.1 to 0.4 µm, lacking the external wall
and containing a granulated chromatin-like material. They were
frequently seen adhered to the endothelial cells of “vasa vasorum” and,
inside the endothelial cells, in the interstitium, and in the cytoplasm of
macrophages usually nearby C. pneumoniae bodies. Necrotic lipidic core
of vulnerable plaques contained many mycoplasmas in a rounded or
elyptical shape and a lot of membranous structures were compatible
with degenerated bacteria (Fig. 3D); in the medial layer and in the
adventitia they were usually found in larger, cylindrical shape, presenting
more electron dense granules, and absent cytoplasmic organelles (Fig.
3C).
In the stable plaques, a lower amount of MP was found.
Mycoplasmas are known as the smallest self-replicating organisms,
requiring cholesterol for surviving because their external membrane is
constituted by cholesterol, a unique property among prokaryotes21. They
have been considered as a parasite of the epithelial surfaces.
In the present study, we found that MP are present in almost all fat
atheroma’s areas, therefore mainly in vulnerable plaques. It believes that
mycoplasmas induce a mild immune response constituted basically of T
cells, and also immunedepression20. Higher amounts of MP was
associated with CD8+ T cells and low number of CD4+ T cells.
Mycoplasmas are capable of oxidizing the host cell membrane inducing
its apoptosis1, favoring the rupture of the plaque. The mycoplasmas could
explain the increased level of cytokines usually observed in vulnerable
plaques22 as it is known they increase release of cytokines by
inflammatory cells6.
Mycoplasmas seem to increase the virulence of other
microorganisms28. The use of a double stained technique confirmed the
electron microscopy findings of co-infected cells. We speculate that
mycoplasmas are usually present in atheromas; the intimal contact
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Table 3
Quantity of Mycoplasma pneumoniae, Chlamydia pneumoniae, lymphocytes and fat in the plaques of the different groups
Group % area of Mean number Mean number % area of fat
M. pneumoniae C. pneumoniae+ cells lymphocytes/mm2
A 32.57 (± 14.76) 35.36 (± 19.30) 16.94 (± 9.16) 44.28 (± 21.68)
B 9.99 (± 6.05) 11.91 (± 23.41) 6.00 (± 7.48) 3.47 (± 6.26)
C 12.15 (± 8.12) 24.00 (47.71) np np
D 0.62 (± 0.60) 3.00 (± 2.57) np np
np = non-performed
Fig. 3 - Detection of Mycoplasma pneumoniae (MP) by in situ hybridization (ISH) and electron microscopy (EM) in vulnerable coronary atheromas. Fig. 3A shows a rupture plaque containing
many brown dots of MP-DNA in the lipid core (ISH technique - 100 X original magnification). Fig. 3B demonstrates foam cells containing many ISH positive dots of MP-DNA (arrows) (ISH
technique - 40X). Fig. 3C - electron micrography showing several MP bodies in a foam cell, and a cylindrical form of MP at the extracellular matrix in the adventitia. Fig. 3D is an electron
microscopy of a necrotic lipid core demonstrating many mycoplasmas, C. pneumoniae elementary bodies and many membranous elements suggestive of degenerated bacteria.
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between MP and intracellular CP bacteria would favor the proliferation
of CP, increase of the inflammatory infiltrate. The inflammatory infiltrate
and many CP would cause enzymatic degradation of the extracellular
matrix, vessel positive remodeling and plaque rupture.
CONCLUSION
In conclusion, in this review we report a series of works of our Lab
that strongly favor the concept that atherosclerosis and plaque rupture
are complications associated with infectious agents. M. pneumoniae is
present in almost all coronary atheromas. The close association between
M. pneumoniae with C. pneumoniae may favor proliferation of both
bacteria that induces to more inflammation and plaque rupture. The great
amount of C. pneumoniae in adventitial fibroblasts and smooth muscle
cells favors the hypothesis that this bacterium participates on the positive
vessel remodeling.
RESUMO
Agentes infecciosos em ateromas coronarianos: um possível papel
na patogênese da ruptura da placa e infarto agudo do miocárdio
Nesta revisão relatamos recentes achados nossos sobre aspectos
histológicos de instabilidade da placa e a associação com Mycoplasma
pneumoniae (MP) e Chlamydia pneumoniae (CP), estudando segmentos
de artéria coronária trombosados de pacientes que faleceram por infarto
agudo do miocárdio. Placas vulneráveis são conhecidas como sendo
placas gordurosas e com inflamação. Aqui demonstramos que a
vulnerabilidade está também relacionada com remodelamento positivo
do vaso o qual pode preservar a luz do vaso mesmo na presença de uma
placa de ateroma grande. Grande quantidade dessas bactérias em placas
vulneráveis está associada a inflamação da adventícia e remodelamento
positivo do vaso: o número médio de linfócitos foi significativamente
maior na adventícia do que na placa, e boas correlações diretas foram
obtidas entre os números médios de células B CD20 e os números de
células infectadas por CP na adventícia, e entre as % de áreas positivas
para MP na placa e as áreas em secção transversal dos respectivos vasos,
sugerindo uma relação de causa - efeito entre esses agentes infecciosos
e vulnerabilidade da placa. Micoplasma é uma bactéria que necessita
colesterol para a proliferação e pode aumentar a virulência de outros
agentes infecciosos. Em conclusão, co-infecção por Mycoplasma
pneumoniae e Chlamydia pneumoniae pode representar um importante
co-fator de instabilidade da placa, levando a trombose da placa
coronariana e infarto agudo do miocárdio, pois a maior quantidade dessas
bactérias mostrou forte correlação com sinais histológicos de maior
vulnerabilidade da placa. A pesquisa nesses tecidos de CMV e
Helicobacter pilori foi negativa.
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